Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual Meeting of Shareholders held earlier today (the “Meeting”) there were 430 shareholders voting in person or by proxy holding in total 280,023,803 common shares of the Company, representing 75.35% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company’s proxy statement dated April 27, 2021 (the “Proxy Statement”) was elected as a director of the Company, with each director receiving in excess of 94.38% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

Name of Director Number of SharesVoted For Percentage of SharesVoted For Number of SharesWithheld fromVoting Percentage of SharesWithheld fromVoting
Jason Adler 213,738,627 97.23% 6,089,643 2.77%
Kendrick Ashton, Jr. 218,960,256 99.61% 868,014 0.39%
Jody Begley 207,466,084 94.38% 12,362,186 5.62%
Murray Garnick 216,385,072 98.43% 3,443,199 1.57%
Michael Gorenstein 210,947,245 95.96% 8,881,025 4.04%
Heather Newman 207,529,001 94.41% 12,299,269 5.59%
James Rudyk 213,776,435 97.25% 6,051,836 2.75%

Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with 93.64% of votes cast in favor of such resolution, and approved the re-appointment of KPMG LLP as the Company’s independent auditors.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR profile at www.sedar.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.

About Cronos GroupCronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™. For more information about Cronos Group and its brands, please visit: www.thecronosgroup.com.

Forward-looking StatementsThis press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward‐looking Statements are not guarantees of future performance and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results and results, performance or achievements expressed or implied by those Forward‐looking Statements.  A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2021, both of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively.  Any Forward‐looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward‐ looking Statement.  Readers are cautioned not to put undue reliance on any Forward‐looking Statement.

Cronos Group ContactShayne LaidlawTel: (416) 504-0004investor.relations@thecronosgroup.com

 

Cronos (NASDAQ:CRON)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Cronos Charts.
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Cronos Charts.